Multiple sclerosis, lupus, type 1 diabetes mellitus, and Hashimoto's thyroiditis are a few examples of autoimmune diseases with cases that are gradually rising in today's society despite the onset of modern technology and advancements in the field of medicine. Considering this, does genetics play a part in the prevalence of these cases? If so, how? Does it also outweigh other risk factors such as lifestyle and environment-related causes? Additionally, what are some specific advancements in the field of genomics that may contribute to minimizing the spread of autoimmune diseases (if your answer to the first question is yes)? Thank you.
top of page
bottom of page
Hi Ron, thank you for visiting ALPHAGEN 3.0 Forums.
Yes, Genetics do in fact play a role in the prevalence of Autoimmune Diseases that are gradually rising in today’s society such as type 1 diabetes mellitus, lupus, etc. Autoimmune diseases are known to have a complex etiology involving both genetic and environmental factors. It is widely acknowledged that genetic susceptibility, epigenetic changes, and environmental factors all play a role in the pathogenesis of autoimmunity. While the exact mechanisms underlying the development of autoimmune diseases are not fully understood, it is widely accepted that genetic factors contribute to an individual's susceptibility to these diseases.
Autoimmune diseases occur when the immune system mistakenly attacks the body's own cells and tissues. Studies in both human and in animal models have indicated that variations in multiple genes can either increase the risk or provide protection against autoimmune diseases. Multiple susceptibility genes have been identified through genome-wide searches in diseases such as rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis. These genes include those found within the major histocompatibility complex (MHC), which is important for immune system function, as well as those found outside of the MHC region. Interestingly, there is evidence that many autoimmune diseases share a common set of susceptibility genes, implying that these conditions share overlapping genetic factors.
We cannot exactly say that genetics outweigh other risk factors since most Autoimmune Diseases are multifactorial in nature, wherein both genetic and environmental factors contribute to disease risk. The genetic risk factors identified thus far have a low penetrance, which means that having the genetic variation does not guarantee disease development. Environmental factors and gene-environment interactions are thought to play a significant role in the onset of autoimmune diseases in people who have a genetic predisposition.
There are specific advancements in the field of genomics that may contribute to minimizing the spread of autoimmune diseases. Here are some specific advancements:
Genome-Wide Association Studies (GWAS): GWAS have identified numerous genetic variants associated with autoimmune diseases and have dominated efforts in gene mapping for autoimmune diseases, and these studies have led to the majority of the new genetic associations. These studies involve analyzing the entire genome to identify common genetic variations that are more frequent in individuals with a particular disease. GWAS findings have provided insights into the genetic architecture of autoimmune diseases, highlighting specific genes and pathways involved in disease development.
Next-Generation Sequencing (NGS): NGS technologies have revolutionized genomics research by enabling high-throughput sequencing of DNA, paying particular attention to autoimmune connective tissue diseases. This has facilitated the discovery of rare genetic variants that were previously difficult to detect. NGS has enhanced our understanding of the genetic basis of autoimmune diseases by identifying rare variants with potentially significant effects on disease risk.
Functional Genomics: Functional genomics approaches, such as gene expression profiling and epigenetic studies, have shed light on the molecular mechanisms underlying autoimmune diseases. These studies have identified gene expression patterns and epigenetic modifications associated with autoimmune diseases, providing insights into disease mechanisms and potential therapeutic targets.
You can read more on these studies that can help you understand more about Autoimmune diseases, their genetic risk factors, and specific technological advancements that play a role in understanding and minimizing the cases of these disorders.
Cooper, G. S., Miller, F. W., & Pandey, J. P. (1999). The role of genetic factors in autoimmune disease: implications for environmental research. Environmental health perspectives, 107 Suppl 5(Suppl 5), 693–700. https://doi.org/10.1289/ehp.99107s5693
Gregersen, P. K., & Olsson, L. M. (2009). Recent advances in the genetics of autoimmune disease. Annual review of immunology, 27, 363–391. https://doi.org/10.1146/annurev.immunol.021908.132653
Long, H., Yin, H., Wang, L., & Lu, Q. (2018). The epigenetics of autoimmunity: An overview. The Epigenetics of Autoimmunity, 1–23. https://doi.org/10.1016/b978-0-12-809912-4.00001-5
Hope this helps!
- Alphagen 3.0